Word

NEUROCRINE BIOSCIENCES

Status

Pending

Status Code

731

Status Date

Tuesday, October 24, 2023

Serial Number

90884742

Mark Type

3000

Filing Date

Monday, August 16, 2021

Published for Opposition

Tuesday, December 13, 2022

Trademark Owner History

Neurocrine Biosciences, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuro-endocrinological diseases, disorders, and conditions; Pharmaceutical preparations for the diagnosis, prevention and treatment of hormonal and genetic diseases, disorders and conditions; Pharmaceutical preparations for the diagnosis and prevention of psychiatric, neurological, central nervous system, and movement diseases, disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

44 providing medical information in the field of hormonal and genetic diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of hormonal and genetic diseases, disorders and conditions

42 pharmaceutical drug development services in the field of hormonal and genetic diseases, disorders and conditions

The mark consists of a stylized circular spiral design with the top spiral piece in aqua blue, the right one starting is aqua blue on the left and fading to pink on the right and the left one in pink with "NEUROCRINE" above "BIOSCIENCES" in block lettering to the right where NEUROCRINE is fading from a darker shade of aqua blue on the left to a lighter shade on the right and BIOSCIENCES in gray.
The color(s) pink, gray and aqua blue is/are claimed as a feature of the mark.
"BIOSCIENCES"

Trademark Events

Oct 25, 2023

Notice Of Approval Of Extension Request E-Mailed

Oct 25, 2023

Corrected Noa E-Mailed

Oct 24, 2023

Sou Extension 2 Granted

Oct 9, 2023

Sou Extension 2 Filed

Oct 24, 2023

Divisional Processing Complete

Oct 9, 2023

Divisional Request Received

Oct 9, 2023

Teas Request To Divide Received

Oct 20, 2023

Case Assigned To Intent To Use Paralegal

Oct 9, 2023

Sou Teas Extension Received

Jul 18, 2023

Notice Of Approval Of Extension Request E-Mailed

Jul 14, 2023

Sou Extension 1 Granted

Jul 14, 2023

Sou Extension 1 Filed

Jul 14, 2023

Sou Teas Extension Received

Feb 7, 2023

Noa E-Mailed - Sou Required From Applicant

Dec 13, 2022

Official Gazette Publication Confirmation E-Mailed

Dec 13, 2022

Published For Opposition

Nov 23, 2022

Notification Of Notice Of Publication E-Mailed

Nov 5, 2022

Approved For Pub - Principal Register

Nov 5, 2022

Teas/Email Correspondence Entered

Nov 4, 2022

Correspondence Received In Law Office

Nov 4, 2022

Teas Response To Office Action Received

May 5, 2022

Notification Of Examiner's Amendment/Priority Action E-Mailed

May 5, 2022

Examiner's Amendment/Priority Action E-Mailed

May 5, 2022

Combined Examiner's Amendment/Priority Action Automatic Entry

May 5, 2022

Examiners Amendment And/Or Priority Action - Completed

May 3, 2022

Assigned To Examiner

Oct 6, 2021

Notice Of Design Search Code E-Mailed

Oct 5, 2021

New Application Office Supplied Data Entered

Aug 19, 2021

New Application Entered